Brief: Alpha Tau Medical Announces Q1 2024 Financial
20/05/2024 21:48
May 20 (Reuters) - Alpha Tau Medical Ltd DRTS.O :
* ALPHA TAU MEDICAL ANNOUNCES FIRST QUARTER 2024 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* QTRLY LOSS PER SHARE $0.11
* AS OF MARCH 31, HAD CASH & CASH EQUIVALENTS, DEPOSITS AND
RESTRICTED DEPOSITS IN AMOUNT OF $80.7 MILLION
* EXPECTS CURRENT CASH BALANCE WILL BE SUFFICIENT TO FUND
ANTICIPATED OPERATIONS FOR AT LEAST TWO YEARS
Source text for Eikon: ID:nGNX84WTr7
Further company coverage: DRTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Tau Medical
See all newsBrief: Alpha Tau Completes Patient Enrollment In Its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal Of FDA Approval Of Alpha Dart® To Treat Recurrent Cutaneous Squamous Cell Carcinoma
Brief: Alpha Tau Announces 100% Local Disease Control Rate And Favorable Safety Profile Observed In Alpha Dart® Pancreatic Cancer Trials Presented At Ddw 2026
Brief: Alpha Tau Medical Files To Offer Up To $300 Million In Securities - SEC Filing
Brief: Alpha Tau Announces First-Ever Oral Presentation Of Alpha Dart® Pancreatic Cancer Data At Digestive Disease Week (Ddw) 2026
Brief: Alpha Tau Medical Receives Japanese Marketing Approval For Alpha Dart In Head And Neck Cancer